Skip to main content
SpringerLink
Log in

Nierenzellkarzinom

  • Chapter
Uroonkologie

  • 18 Accesses

Zusammenfassung

Mehr als 85% aller malignen Nierentumoren sind Nierenzellkarzinome. Histologisch imponieren sie als „Adenokarzinom“, daneben erscheinen auch Transitionalzellkarzinome, Nephroblastome, Sarkome und Metastasen anderer Karzinome in der Niere (vgl. Tabelle 2.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abubakr YA, Ta-Hsu C, Redman B (1994) Sponateous remission of renal cell carcinoma: a case report and immunological correlates. J Urol 152:156–157

    PubMed  CAS  Google Scholar 

  • Alexander RB, Linehan WM (1993) editorial comment. J Urol 150:1390

    Google Scholar 

  • Amendola MA, King LR, Pollack HM, Gefter W, Kressel HY, Wein AJ (1990) Staging of renal carcinoma using magnetic resonance imaging at 1.5 Tesla. Cancer 66:40–44

    Article  PubMed  CAS  Google Scholar 

  • Angervall L, Wahlquist L (1978) Follow-up and prognosis of renal carcinoma in a series operated by perifascial nephrectomy combined with adrenalectomy and retroperitoneal lymphadenectomy. Eur Urol 4:13

    PubMed  CAS  Google Scholar 

  • Aso Y, Homma Y (1992) A survey on incidental renal cell carcinoma in Japan. J Urol 147:340–343

    PubMed  CAS  Google Scholar 

  • Atzpodien J, Körfer A, Franks CR, Poliwoda H, Kirchner H (1990) Home therapy with recominant interleukin-2 and interferon-alpha-2b in advanced human malignancies. Lancet 335:1509–1512

    Article  PubMed  CAS  Google Scholar 

  • Bander NH (1987) Monoclonal antibodies: state of the art. J Urol 137:603–612

    PubMed  CAS  Google Scholar 

  • Belldegrun A, Webb DE, Austin III HA, Steinberg SM, Linehan WM, Rosenberg SA (1989) Renal toxicity of interleukin-2 administration in patients with metastatic renal cell cancer: effect of pre-therapy nephrectomy. J Urol 141:499–503

    PubMed  CAS  Google Scholar 

  • Belldegrun A, Koo AS, Bochner B, Figlin R, de Kernion JB (1990) Immunotherapy for advanced renal cell cancer the role of radical nephrectomy. Eur Urol 18 [Suppl 2]: 42–45

    PubMed  Google Scholar 

  • Belldegrun A, Pierce W, Kaboo R et al. (1993) Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma. J Urol 150:1384–1390

    PubMed  CAS  Google Scholar 

  • Berg-Schlosser V (1988) Radiologische Diagnostik maligner Nierentumoren. Dtsch Arztebl 85: 390–394

    Google Scholar 

  • Blackley SK, Ladaga L, Woolfitt RA, Schellhammer PF (1988) Ex situ study of the effectiveness of enucleation in patients with renal cell carcinoma. J Urol 140:6–10

    PubMed  CAS  Google Scholar 

  • Bloom DA, Kaufman JJ, Smith RB (1981) Late recurrence of renal tubular carcinoma. J Urol 126: 546–648

    PubMed  CAS  Google Scholar 

  • Böttcher HD (1996) Tumoren der Niere und Harnleiter. In: Scherer E, Sack H (Hrsg) Strahlentherapie — Radiologische Onkologie. 4. Aufl. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Bretan PN, Busch MP, Hricak H (1986) Development of acquired renal cysts and renal cell carcinoma. Cancer 57:1871–1879

    Article  PubMed  Google Scholar 

  • Brkovic D, Riedasch G, Waldherr R, Röhl L, Staehler G (1994) Lokale Rezidive nach organerhaltender Nierentumorchirurgie. Urologe A 33:104–109

    CAS  Google Scholar 

  • Bülow H, Sebeikat D, Demetriou D (1991) Ist die Arenalektomie bei der Tumornephrektomie immer erforderlich? Urologe A 30:341–343

    PubMed  Google Scholar 

  • Carini M, Selli C, Barbanti G, Lapini A, Turini D, Costatini A (1988) Conservative surgical treatment of renal cell carcinoma: clinical experience and reappraisal of indications. J Urol 140:725–731

    PubMed  CAS  Google Scholar 

  • Carl P, Klein U, Gebauer A, Schmiedt E (1977) The value of lymphography for the TNM classification of renal carcinoma. Eur Urol 3:286–288

    PubMed  CAS  Google Scholar 

  • Cheng WS, Farrow GM, Zincke H (1991) The incidence of multicentricity in renal cell carcinoma. J Urol 146:1221–1223

    PubMed  CAS  Google Scholar 

  • Dalla-Palma L, Pozzi-Mucelli F, di Donna A, Pozzi-Mucelli RS (1990) Cystic renal tumors: US and CT findings. Urol Radiol 12:67–73

    Article  PubMed  CAS  Google Scholar 

  • Damascelli B, Marchiano A, Spreafico C et al. (1990) Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump. Cancer 66:237–241

    Article  PubMed  CAS  Google Scholar 

  • DeKernion JB, Berry D (1980) The diagnosis and treatment of renal cell carcinoma. Cancer 45: 1947–1956

    PubMed  CAS  Google Scholar 

  • DeKernion JB, Huland H (1990) The operable renal cell carcinome: Summary and conclusions. Eur Urol [Suppl 2] 148–51

    Google Scholar 

  • Dexeus FH, Logothetis CJ, Sella A et al. (1991) Circadian infusion of floxuridin in patients with metastatic renal cell carcinoma. J Urol 146:709–713

    PubMed  CAS  Google Scholar 

  • Dineen MK, Pastore RD, Emrich LJ, Huben RP (1988) Results of surgical treatment of renal cell carcinoma with solitary metastasis. Urol 140:277–279

    CAS  Google Scholar 

  • Eilerhorst JA, Kilbourn RG, Amato RJ et al. (1994) Phase II trial of low dose gamma-interferon in metastatic renal cell carcinoma. J Urol 152:841–845

    Google Scholar 

  • Elson PJ, Witte RS, Trump DL (1988) Prognostic facors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48:7310–7313

    PubMed  CAS  Google Scholar 

  • Eschenbach AC von, Avallone A, Price J, Swanson D, Killion J, Stephenson R, Fidler IJ (1990) The biology of renal cancer the influence of nephrectomy. Eur Urol 18 [Suppl 2] 140–41

    Google Scholar 

  • Flocks RH, Kadesky MC (1958) Malignant neoplasms of the kidney: an analysis of 353 patients followed 5 years or more. J Urol 79:196

    PubMed  CAS  Google Scholar 

  • Fossa SD, Stenwig AE, Lien HH (1991) Long-term results in patients with metastatic renal cell carcinoma treated with interferon with or without vinblastine. World J Urol 9:210–214

    Article  Google Scholar 

  • Fowler JE Jr (1986) Failure of immunotherapy for metastatic renal cell carcinoma. J Urol 135:22–25

    PubMed  Google Scholar 

  • Gill IS, McClennan BL, Kerbl K, Carbone JM, Wick M, Clayman RV (1994) Adrenal involvement from renal cell carcinoma: predictive value of computerized tomography. J Urol 152:1082–1085

    PubMed  CAS  Google Scholar 

  • Giuliani L, Giberti C, Martorana G, Rovida S (1990) Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 143:468–474

    PubMed  CAS  Google Scholar 

  • Goepel M, Rübben H (1991) Adjuvant therapy in renal cancer. World J Urol 9:232–236

    Article  Google Scholar 

  • Goldfarb DA, Novick AC, Lorig R et al. (1990) Magnetic resonance imaging for assessment of vena caval tumor thrombi: a comparative study with venocavography and computerized tomography scanning. J Urol 144:1100–1104

    PubMed  CAS  Google Scholar 

  • Golimbu M, Al-Askari S, Tessler A, Morales P (1994) Aggressive treatment of metastatic renal cancer. J Urol 136:805–807

    Google Scholar 

  • Grignon DJ, Ayala AG, El-Naggar A et al. (1989) Renal cell carcinoma — a clinico pathologic and DNA flow cytometric analysis of 103 cases. Cancer 64:2133–2140

    Article  PubMed  CAS  Google Scholar 

  • Grossman HB, Sommerfeld D, Konnak JW, Bromberg J (1994) Long-term assessment of renal function following nephrectomy for stage I renal carcinoma. Br Urol 74:279–282

    Article  CAS  Google Scholar 

  • Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE (1991) Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 145:20–24

    PubMed  CAS  Google Scholar 

  • Hellsten S, Johnsen J, Berge T, Linell F (1990) Clinically unrecognized renal cell carcinoma. Eur Urol 18 [Suppl 2]: 2–3

    PubMed  Google Scholar 

  • Hermanek, P, Schrott KM (1990) Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. J Urol 144:238–242

    PubMed  CAS  Google Scholar 

  • Herrlinger A, Schrott KM, Schott G, Sigel A (1991) What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma? J Urol 146:1224–1227

    PubMed  CAS  Google Scholar 

  • Horoszewicz JS, Murphy GP (1989) An assessment of the current use of human interferons in therapy of urological cancers. J Urol 142:1173–1179

    PubMed  CAS  Google Scholar 

  • Hovsepian DM, Levy H, Amis ES Jr, Newhouse JH (1990) MR evaluation of renal space-occupving lesions: diagnostic criteria. Urol Radiol 12:74–79

    Article  PubMed  CAS  Google Scholar 

  • Hulten L, Rosencrantz M, Seeman T, Wahlquist L, Ahren C (1969) Occurrence and localization of lymph node metastases in renal cell carcinoma. A lymphographic and histopathological investigation in connection with nephrectomy. Scand I Urol Nephrol 3:129

    Article  CAS  Google Scholar 

  • Jakse G (1989) Operative Technik beim Nierentumor mit Cavathrombus. Aktuel Urol 20:V-X

    Article  Google Scholar 

  • Kish J, Ensley J. Al-Sarraf M, Ratanatharathorn V, Karanes C, Galicky P (1986) Activity of serine substituted recombinant DNA ß interferon (IFN ß) in patients with metastatic and recurrent renal cell cancer. Proc Am Assoc Cancer Res 27:184

    Google Scholar 

  • Kuebler JP, Whitehead RP, Ward DL et al. (1993) Treatment of metastatic renal cell carcinoma with recombinant interleukin-2 in combination with vinblastine or lymphokine-activated killer cells. J Urol 150:814–820

    PubMed  CAS  Google Scholar 

  • Kühn R, Bornhof Ch, Giedl J (1991) Klinik und Wertigkeit renaler Onkozytome. Urologe A 30: 337–340

    PubMed  Google Scholar 

  • Kuhn FP, Altwein JE (1980) Nierenadenome: Dignität, Klinik und Therapie. Urol Int 35:258–270

    Article  PubMed  CAS  Google Scholar 

  • Lee SE, Kim HH (1994) Validity of kidney-preserving surgery for localized renal cell carcinoma. Eur Urol 25:204–208

    PubMed  CAS  Google Scholar 

  • Levens W, Rübben H, Ingenhag W (1989) Long-term interferon treatment in metastatic renal cell carcinoma. Eur Urol 16:378–381

    PubMed  CAS  Google Scholar 

  • Levinson AK, Johnson DE, Strong LC, Pathak S, Huff V, Saunders GF (1990) Familial renal cell carcinoma: hereditary or coincidental? J Urol 144:849–851

    PubMed  CAS  Google Scholar 

  • Licht MR, Novick AC, Goormastic M (1994) Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol 152:39–42

    PubMed  CAS  Google Scholar 

  • Ljungberg B, Stenlig R, Roos C (1986) Prognostic value of deoxyribonucleic acid content in metastatic renal cell carcinoma. J Urol 136:801–814

    PubMed  CAS  Google Scholar 

  • Ljungberg B, Holmberg G, Sjödin JG, Hietala SO, Stenling R (1990) Renal cell carcinoma in a renal cyst: a case report and review of the literature. J Urol 143:797–799

    PubMed  CAS  Google Scholar 

  • Ljungberg B, Larsson P, Stenling R, Roos G (1991) Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma. J Urol 146:697–699

    PubMed  CAS  Google Scholar 

  • Malek RS, Omess PJ, Benson RC Jr, Zincke H (1987) Renal cell carcinoma in von Hippel-Lindau-Syndrome. Am J Med 82:236–240

    Article  PubMed  CAS  Google Scholar 

  • Maloney KE, Norman RW, Lee CLY, Millard OH, Welch JP (1991) Cytogenetic abnormalities associated with renal cell carcinoma. J Urol 146:692–696

    PubMed  CAS  Google Scholar 

  • Marberger M (1988) Organerhaltende Nierentumorexzision. Akt Urol 19, 2:58–66

    Article  Google Scholar 

  • Marshall FF (1993) editorial comment. J Urol 150:323

    Google Scholar 

  • Marshall FF, Powell KC (1982) Lymphadenectomy for renal cell carcinoma: anatomical and therapeutic considerations. J Urol 128:677–681

    PubMed  CAS  Google Scholar 

  • Marshall FF, Ferguson J, Reitz BA (1990) Operative management of renal cell carcinoma with suprahepatic intracaval neoplastic extension. Eur Urol 18 [Suppl 2]: 26–28

    PubMed  Google Scholar 

  • McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long-term survival and late recurrence. J Urol 126:17–23

    PubMed  CAS  Google Scholar 

  • Middleton RG, Presto AJ (1973) Radical thoracoabdominal nephrectomy for renal cell cancer. J Urol 110:36

    PubMed  CAS  Google Scholar 

  • Mittelmann A, Hubermann M, Puccio C et al. (1990) A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma. Cancer 66:664–669

    Article  Google Scholar 

  • Moll V, Becht E, Ziegler M (1993) Kidney preserving surgery in renal cell tumors: indications, technique and results in 152 patients. I Urol 150:319–323

    CAS  Google Scholar 

  • Möller JD, Esteve J, Möller H, Renard H (1990) Cancer in the European Community and its member states. Eur J Cancer 26 11/12:1167–1256

    PubMed  Google Scholar 

  • Montie JE, Novick AC (1988) Partial nephrectomy for renal cell carcinoma (editorial) (1988). J Urol 140:129–130

    PubMed  CAS  Google Scholar 

  • Morgan WR, Zincke H (1990) Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended follow-up. J Urol 144:852–858

    PubMed  CAS  Google Scholar 

  • Mukamel E, Konichezky M, Engelstein D, Servadio C (1988) Incidental small renal tumors accompanying clinically overt renal cell carcinoma. J Urol 140:22–24

    PubMed  CAS  Google Scholar 

  • Muss HB (1987) Interferon therapy for renal cell carcinoma. Semin Oncol 14 [Suppl] 2:34–42

    Google Scholar 

  • Naito S, Kimiya K, Sakamoto N et al. (1991) Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma. Urology 37:95–99

    Article  PubMed  CAS  Google Scholar 

  • Negrier S, Philip T, Stoter G et al. (1990) Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of European multicenter study. Eur J Cancer Clin Oncol 25 [Suppl 3]: 21–28

    Google Scholar 

  • Novick AC, Streem S, Montic JE, Pontes JE, Siegel S. Montague DK, Goormastic M (1989) Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol 141: 835–839

    PubMed  CAS  Google Scholar 

  • Otto U, Baisch H, Klöppel G, Huland H (1990) Tumor heterogeneity of renal cell carcinoma. Eur Urol 18 [Suppl 2]: 38–39

    Google Scholar 

  • Paganini-Hill A, Ross RK, Henderson BE (1988) Epidemiology of renal cancer. In: Skinner DG, Lieskovsky G (eds) Treatment of genitourinary cancer. Saunders, Philadelphia

    Google Scholar 

  • Pizzocaro G (1986) Lymphadenectomy in renal adenocarcinoma. In: DeKernion JB, Pavone-Macaluso M (eds) Tumors of the kidney. International perspectives in urology, vol 13. Williams & Wilkins, Baltimore, p 75

    Google Scholar 

  • Pizzocaro G, Piva L, Salvoni R, die Fronzo G, Ronchi E, Miodini P and the Lombardy Group (1986) Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M 0 renal cell carcinoma. An interim report of a prospective, randomized study. J Urol 135:18–21

    PubMed  CAS  Google Scholar 

  • Poppel H van, Claes H, Willemen P, Oyen R, Baert L (1991) Is there a place for conservative surgery of renal carcinoma? Br Urol 67:129–133

    Article  Google Scholar 

  • Provet J, Tessler A, Brown J, Golimbu M, Bosniak M, Morales P (1991) Partial nephrectomy for renal cell carcinoma: indications, results and implications. J Urol 145:472–476

    PubMed  CAS  Google Scholar 

  • Rafla S (1970) Renal cell carcinoma: natural history and results of treatment. Cancer 25:26 19970

    Article  Google Scholar 

  • Rainwater LM, Hosaka Y, Farrow GM, Lieber MM (1987) Well differentiated clear cell renal carcinoma: significance of nuclear deoxyribonucleic acid patterns studied by flow cytometry. J Urol 137:15–20

    PubMed  CAS  Google Scholar 

  • Rainwater LM, Zincke H, Farrow GM, Gonchoroff NJ (1991) Renal cell carcinoma in young and old patients comparison of prognostic pathologic variables (cell type, tumor grade and stage, DNA ploidy pattern) and their impact on disease outcome. Urology 38:1–5

    Article  PubMed  CAS  Google Scholar 

  • Robey EL, Schellhammer PF (1986) The adrenal gland and renal cell carcinoma: is ipsi lateral adrenalectomy a necessary component of radical nephrectomy? J Urol 135:453–457

    PubMed  CAS  Google Scholar 

  • Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297–301

    PubMed  CAS  Google Scholar 

  • Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318–1321

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg SA, Lotze MT, Muul LM et al. (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin alone. N Engl J Med 316:889–897

    Article  PubMed  CAS  Google Scholar 

  • Rosenthal EL, Kraft R, Zingg EJ (1984) Organ-preserving surgery in renal cell carcinoma: tumor enucleation versus partial kidney resection. Eur Urol 10:222–228

    PubMed  CAS  Google Scholar 

  • Ruiz JL, Vera C, Server G, Osca JM, Boronat F, Jimenez Cruz JF (1991) Renal cell carcinoma: late recurrence in 2 cases. Eur Urol 20:167–169

    PubMed  CAS  Google Scholar 

  • Sanchez de la Muela P, Zudaire JJ, Robles JE et al. (1991) Renal cell carcinoma: vena caval invasion and prognostic factors. Eur Urol 19:284–290

    Google Scholar 

  • Schärfe T, Thüroff JW, Alken P, Riedmiller H, Jacobi GH, Hohenfellner R (1988) Konservative Chirurgie des Nierenzellkarzinoms — Technik und Verlauf von 84 Patienten. Aktuel Urol 19. 2: 67–71

    Article  Google Scholar 

  • Schornagel JH, Verweij J, ten Bokkel Huinink WW et al. (1989) Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinoma. J Urol 112:253–256

    Google Scholar 

  • Shimizu M, Yokota J, Mori N et al. (1990) Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Oncogene 5:185–194

    PubMed  CAS  Google Scholar 

  • Siminovitch JP, Montie JE, Straffon RA (1982) Lymphadenectomy in renal adenocarcinoma. J Urol 127:1090

    PubMed  CAS  Google Scholar 

  • Skinner DG, Colvin RB, Vermillon CD, Pfister RC, Leadbetter WL (1971) Diagnosis and management of renal cell carcinoma. Cancer 8:1165–1177

    Article  Google Scholar 

  • Staehler G, Drehmer I, Pomer S (1994) Tumorbefall der Vena cava beim Nierenzellkarzinom. Urologe A 33:116–121

    PubMed  CAS  Google Scholar 

  • Steinbach F, Stöckle M, Thüroff JW et al. (1991) Parenchyma-sparing surgery for renal tumors — experience in over 120 patients. World J Urol 9:178–183

    Article  Google Scholar 

  • Störkel S, Thoenes-W, Jacobi GH, Engelmann U, Lippold R (1990) Prognostic parameters of renal cell carcinoma. Eur Urol 18 [Suppl 21:36–37

    PubMed  Google Scholar 

  • Strohmeyer TG, Slamon DJ (1994) Proto-oncogenes and tumor suppressor genes in human urological malignancies. J Urol 151:1479–1497

    PubMed  CAS  Google Scholar 

  • Swanson DA, Borges PM (1983) Complications of transabdominal radical nephrectomy for renal cell carcinoma. J Urol 129:704–707

    PubMed  CAS  Google Scholar 

  • Takatera H, Maeda O, Toshirsugu O et al. (1986) Solitary late recurrence of renal cell carcinoma. J Urol 136:799–801

    PubMed  CAS  Google Scholar 

  • Tammela TLJ, Leinonen ASS, Konturri MJ (1991) Comparison excretory urography, angiography, ultrasound and computed tomography for T category staging of renal cell carcinoma. Scand J Urol Nephrol 25:283–286

    Article  PubMed  CAS  Google Scholar 

  • Thoenes W, Störkel S, Rumpelt HJ (1986) Histopathology of renal cell tumors (adenomas, oncocytomas and carcinomas): the basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125–143

    Article  PubMed  CAS  Google Scholar 

  • Thompson IM, Peek M (1988) Improvement in survival of patients with renal cell carcinoma — the role of the serendipitously detected tumor. J Urol 140:187–490

    Google Scholar 

  • Tosaka A, Ohya K, Yamada K, Ohashi H, Kitahara S, Sekine H, Takehara Y, Oka K (1990) Incidence and properties of renal massas and asymptomatic renal cell carcinoma detected by adominal ultrasonography. J Urol 144:1097–1099

    PubMed  CAS  Google Scholar 

  • Ueda T, Yasumasu T, Uozomi J, Naito S (1991) Comparison of clinical and pathological characteristics in incidentally detected and suspected renal carcinoma. Br J Urol 68:470–472

    Article  PubMed  CAS  Google Scholar 

  • Weaver DJ, Michalski K, Miles JH (1988) Cytogenetic analyses in renal cell carcinoma: correlation with tumor aggressiveness. Cancer Res 48:2887–2889

    PubMed  CAS  Google Scholar 

  • Weaver DJ, Michalski K, Miles J (1989) Cytogenetics of bilateral renal cell carcinoma. J Urol 142: 697–700

    PubMed  CAS  Google Scholar 

  • West WH, Tauer KW, Yanelli IR, Marshall GD, Orr DW, Thurmann GB, Oldham RK (1987) Constant-infusion of recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316:898–905

    Article  PubMed  CAS  Google Scholar 

  • Wimer P, Miersch W-D, Vogel J, Jaeger N (1990) On the necessity of adrenal extirpation combined with radical nephrectomy. J Urol 144:842–844

    Google Scholar 

  • Wirth M (1991) Stellenwert der Interferone, des Interleukin 2 und des Tumornekrosefaktors in der Therapie des Nierenzellkarzinoms. Urologe A 30:77–80

    PubMed  CAS  Google Scholar 

  • Zincke H, Sen SE (1988) Experience with extracorporal surgery and autotransplantation for renal cell and transitional cell cancer of the kidney. J Urol 140:25–27

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. W. Boeckmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Jakse
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Urologische Klinik und Poliklinik, Medizinische Einrichtungen der Universität-GHS Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Herbert Rübben (Direktor der Urologischen Klinik und Poliklinik) (Direktor der Urologischen Klinik und Poliklinik)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Boeckmann, W., Jakse, G. (1997). Nierenzellkarzinom. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10731-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10731-7_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10732-4

  • Online ISBN: 978-3-662-10731-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation